Rochdale Investment Management »

Keryx Biopharmaceuticals shares owned by Rochdale Investment Management

Quarter-by-quarter ownership of Keryx Biopharmaceuticals shares owned by Rochdale Investment Management from 13F filings

Historical chart of Rochdale Investment Management investment in Keryx Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Keryx Biopharmaceuticals held by Rochdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keryx Biopharmaceuticals by Rochdale Investment Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $26k 10k 2.60
2012-09-30 $28k 10k 2.80
2012-06-30 $18k 10k 1.80
2012-03-31 $50k 10k 5.00
2011-12-31 $25k 10k 2.50
2011-09-30 $30k 10k 3.00
2011-03-31 $101k 20k 5.01

More positions owned by Rochdale Investment Management

Verizon Communications (VZ)
Philip Morris International (PM)
At&t (T)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Altria (MO)
Northeast Utilities System
Bristol Myers Squibb (BMY)
National Retail Properties (NNN)
Plains All American Pipeline (PAA)
Xcel Energy (XEL)
UIL Holdings Corporation
Vector (VGR)
Exxon Mobil Corporation (XOM)
Health Care REIT
B&G Foods (BGS)

View all positions for Rochdale Investment Management

Top funds holding Keryx Biopharmaceuticals

Huntington National Bank

View all funds holding Keryx Biopharmaceuticals